共识指南 第103页
排序
PrimaryCutaneousLymphomas2023.V1EN
National ComprehensiveNCCNCancer NetworkRNCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)Primary CutaneousLymphomasVersion 1.2023-January 5,2023NCCN.orgContinue
会员专属
PenileCancer2023.V1EN
National ComprehensiveNCCNCancer NetworkRNCCN Clinical Practice Guidelines in Oncology(NCCN Guidelines)Penile CancerVersion 1.2023-December 1,2022NCCN.orgContinue
PediatricHodgkinLymphoma2023.V2EN
National ComprehensiveNCCNCancer NetworkRNCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)PediatricHodgkin LymphomaVersion 2.2023-March 9,2023NCCN.orgContinue
PediatricCentralNervousSystemCancers2023.V2EN
National ComprehensiveNCCNCancer NetworkRNCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)Pediatric Centra NervousSystem CancersVersion 2.2023-October 31,2022NCCN.org...
PediatricAggressiveMatureB-CellLymphomas2023.V1EN
National ComprehensiveNCCNCancer NetworkRNCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)Pediatric AggressiveMature B-Cell LymphomasVersion 1.2023-April 4,2023NCCN.o...
PARP抑制剂在卵巢癌中的应用美国临床肿瘤学会指南快速更新推荐解读
·34.实用妇产科杂志2023年1月第39卷第1期Journal of Pradical Olstetries and Gyneology2023anVd.39,Na.1文章编号：1003-6946(2023)01-0034-04PARP抑制剂在卵巢癌中的应用美国临床肿瘤学会指南...
PancreaticAdenocarcinoma2023.V1EN
National ComprehensiveNCCNCancer NetworkRNCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)PancreaticAdenocarcinomaVersion 1.2023-May 4,2023NCCN.orgNCCN Guidelines for...
OvarianCancerFallopianTubeCancerPrimaryPeritonealCancer2023.V1EN
National ComprehensiveNCCNCancer NetworkRNCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)Ovarian CancerIncluding Fallopian Tube Cancerand Primary Peritoneal CancerVe...
OccultPrimary2023.V3EN
National ComprehensiveNCCNCancer NetworkNCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines)Occult Primary(Cancer of Unknown Primary [CUP])Version 3.2023-December 21,202...
MyeloproliferativeNeoplasms2023.V1EN
National ComprehensiveNCCNCancer NetworkRNCCN Clinical Practice Guidelines in Oncology(NCCN Guidelines)MyeloproliferativeNeoplasmsVersion 1.2023-May 19,2023NCCN.orgNCCN Guidelines ...
